Literature DB >> 31655143

DSE associated musculocontractural EDS, a milder phenotype or phenotypic variability.

Schaida Schirwani1, Kay Metcalfe2, Bart Wagner3, Ian Berry4, Glenda Sobey5, Rosalyn Jewell6.   

Abstract

Musculocontractural Ehlers-Danlos syndrome (mcEDS) is an autosomal recessive condition characterized by distinct craniofacial features, multisystem congenital malformations and progressive fragility of connective tissues. It is caused by pathogenic variants in CHST14 and DSE genes. There are three reports of pathogenic variants in DSE in four mcEDS patients. In this study we provide clinical and molecular presentation of two new patients with DSE related mcEDS. Analysing clinical exome data, a homozygous pathogenic DSE variant, c.1150_1157del p.(Pro384Trpfs*9), was identified in a 32 year old man with bilateral congenital talipes equinovarus, characteristic facial features, myopia, hyperextensible skin at the elbows, significant palmar wrinkling, bilateral inguinal hernias and chronic leg, back and joint pain. Electron microscopical examination of skin biopsy showed changes consistent with mild compensatory elastic fibre hypertrophy and mildly loose collagen bundles. The variant is predicted to result in a frameshift and introduction of a premature termination codon in the final exon of the DSE gene, anticipated to lead to the loss of approximately 60% of the normal reading frame. The second patient has a phenotype consistent with previously reported cases of DSE associated musculocontractural EDS. A novel homozygous missense DSE variant of uncertain clinical significance was detected. This case study further delineates the DSE associated mcEDS phenotype and illustrates absence of major cutaneous, cardiovascular, renal and respiratory features, which supports previous suggestions that patients with DSE associated mcEDS present with a milder phenotype compared to those with CHST14 mutations.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Adducted thumb-clubfoot syndrome; CHST14; DSE; EDS; Ehlers-Danlos syndrome; Ehlers-Danlos syndrome kosho type; Musculocontractural; Proteoglycans; mcEDS

Year:  2019        PMID: 31655143     DOI: 10.1016/j.ejmg.2019.103798

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  9 in total

Review 1.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

2.  Ehlers Danlos Syndrome with Glycosaminoglycan Abnormalities.

Authors:  Noriko Miyake; Tomoki Kosho; Naomichi Matsumoto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  The Specific Role of Dermatan Sulfate as an Instructive Glycosaminoglycan in Tissue Development.

Authors:  Shuji Mizumoto; Shuhei Yamada
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

4.  Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency.

Authors:  Charlotte K Lautrup; Keng W Teik; Ai Unzaki; Shuji Mizumoto; Delfien Syx; Heng H Sin; Irene K Nielsen; Sara Markholt; Shuhei Yamada; Fransiska Malfait; Naomichi Matsumoto; Noriko Miyake; Tomoki Kosho
Journal:  Mol Genet Genomic Med       Date:  2020-03-04       Impact factor: 2.183

Review 5.  Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome.

Authors:  Tomoki Kosho; Shuji Mizumoto; Takafumi Watanabe; Takahiro Yoshizawa; Noriko Miyake; Shuhei Yamada
Journal:  Genes (Basel)       Date:  2019-12-29       Impact factor: 4.096

6.  The structure of human dermatan sulfate epimerase 1 emphasizes the importance of C5-epimerization of glucuronic acid in higher organisms.

Authors:  Mahmudul Hasan; Hamed Khakzad; Lotta Happonen; Anders Sundin; Johan Unge; Uwe Mueller; Johan Malmström; Gunilla Westergren-Thorsson; Lars Malmström; Ulf Ellervik; Anders Malmström; Emil Tykesson
Journal:  Chem Sci       Date:  2020-12-08       Impact factor: 9.825

7.  Clinical and molecular features of 66 patients with musculocontractural Ehlers-Danlos syndrome caused by pathogenic variants in CHST14 (mcEDS-CHST14).

Authors:  Mari Minatogawa; Ai Unzaki; Hiroko Morisaki; Delfien Syx; Tohru Sonoda; Andreas R Janecke; Anne Slavotinek; Nicol C Voermans; Yves Lacassie; Roberto Mendoza-Londono; Klaas J Wierenga; Parul Jayakar; William A Gahl; Cynthia J Tifft; Luis E Figuera; Yvonne Hilhorst-Hofstee; Alessandra Maugeri; Ken Ishikawa; Tomoko Kobayashi; Yoko Aoki; Toshihiro Ohura; Hiroshi Kawame; Michihiro Kono; Kosuke Mochida; Chiho Tokorodani; Kiyoshi Kikkawa; Takayuki Morisaki; Tetsuyuki Kobayashi; Takaya Nakane; Akiharu Kubo; Judith D Ranells; Ohsuke Migita; Glenda Sobey; Anupriya Kaur; Masumi Ishikawa; Tomomi Yamaguchi; Naomichi Matsumoto; Fransiska Malfait; Noriko Miyake; Tomoki Kosho
Journal:  J Med Genet       Date:  2021-11-23       Impact factor: 5.941

8.  Case report: Multiple gastrointestinal perforations in a rare musculocontractural Ehlers-Danlos syndrome with multiple organ dysfunction.

Authors:  Huitao Qian; Tao Zhou; Nan Zheng; Qiulun Lu; Yi Han
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

Review 9.  Ehlers-Danlos syndromes and their manifestations in the visual system.

Authors:  Samuel Asanad; May Bayomi; Douglas Brown; Joshua Buzzard; Eric Lai; Carlthan Ling; Trisha Miglani; Taariq Mohammed; Joby Tsai; Olivia Uddin; Eric Singman
Journal:  Front Med (Lausanne)       Date:  2022-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.